Share
12,470 Posts.
lightbulb Created with Sketch. 3377
clock Created with Sketch. 20/12/22
18:29
Share
Originally posted by JB1975:
↑
I've got the public MSB announcements (suggesting potency assays that we're updates on what was used in GVHD001 (ie TNFR1 and/or IL2R alpjha would be the only qualifiers for that - not INFgamma - had MSB introduced an INFgamma potency assay I think they'd have said so - but doing that would carry the problem of suggesting product lots that were produced when it wasn't used - (because its also an inhibitor of T cell proliferation might have more than one possible plausible cause of potency - a potential problem for them) like pretty much all of them (past trials on remestemcel-L) including the clinical trial data could be confounded) and the Blinker and Bauer paper was Feb 2021. Not quite two years on that yet.
Expand
You seem to enjoy digging up the details, which is fine - but, at what point do you have to park it and say this is futile - as there's simply not enough info in the public that will satisfy your search.
(20min delay)